InvestorsHub Logo
Followers 7
Posts 98
Boards Moderated 0
Alias Born 06/09/2020

Re: Protector post# 336892

Thursday, 02/18/2021 11:47:40 AM

Thursday, February 18, 2021 11:47:40 AM

Post# of 346461
But you said that this would be Janssen's first Enhanze target. That is false.

https://www.halozyme.com/investors/news-releases/news-release-details/2020/Halozyme-Announces-Janssen-Receives-FDA-Approval-Of-DARZALEX-FASPRO-Utilizing-Halozymes-ENHANZE-Technology-For-The-Treatment-Of-Patients-With-Multiple-Myeloma/default.aspx

The first target Janssen got approved was May of 2020. Halozyme sold product to Janssen throughout 2020 to support that launch. I do not believe Avid made much of it for them, as I believe it was done at Catalent.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News